Uterine leiomyosarcoma is a high-grade sarcoma that might be associated with dismal outcome. There are no hematological markers that can be used to follow up the recurrence and/or progression of the tumor. We present a case of a 44-year-old female, who was diagnosed with uterine leiomyosarcoma. During her management course, serum beta human chorionic gonadotropin (β-hCG) elevation was correlated with clinical and radiological disease progression on two separate occasions. This correlation should be further investigated to potentially integrate serum β-hCG as a predictive tool for clinical behavior and treatment response.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807911 | PMC |
| http://dx.doi.org/10.14740/wjon1748 | DOI Listing |
Publication Analysis
Top Keywords
uterine leiomyosarcoma
12
beta human
8
human chorionic
8
chorionic gonadotropin
8
disease progression
8
significance beta
4
gonadotropin predicting
4
predicting disease
4
progression uterine
4
leiomyosarcoma uterine
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!